However, although TTN (12%), MUC4 (14%) and MUC16 (14%) commonly mutated in ACC (Fig. 1B), these mutations did not seem to be correlated with the efficacy of ICIs for ACC cases. Here, MUC16 is linked to adrenal cortex carcinoma.